Form 4: Atara Biotherapeutics Executive Sells Shares to Cover Tax Obligations

Eric J. Hyllengren, EVP, CFO and COO of Atara Biotherapeutics, sold 1,364 shares of common stock to cover tax obligations related to vesting restricted stock units.

Summary

• Eric J. Hyllengren, an executive at Atara Biotherapeutics, sold 1,364 shares of the company's common stock on November 18, 2024.
• The sale was executed to cover tax withholding obligations associated with the vesting of previously granted restricted stock units.
• The shares were sold at a weighted average price of $11.198 per share.
• Following the transaction, Mr. Hyllengren still beneficially owns 23,392 shares of Atara Biotherapeutics stock.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction for tax purposes, not indicative of positive or negative sentiment.

Industry Context

This is a routine transaction for executives who receive stock-based compensation. It is common for executives to sell shares to cover tax obligations when restricted stock units vest.

Comparison to Industry Standards

• Sales of shares by executives to cover tax obligations are a common practice across the industry.
• Many companies use restricted stock units as part of their compensation packages, leading to similar sales by executives at other companies.
• The sale price of $11.198 is within the range of recent trading prices for Atara Biotherapeutics stock.

Stakeholder Impact

• The sale of shares by an executive may have a minor impact on the stock price, but it is not expected to be significant.

Key Dates

Keywords

Atara Biotherapeutics, insider trading, stock sale, executive, tax obligations, restricted stock units, ATRA